Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Unraveling the autoimmune translational research process layer by layer.

Literature DB >> 22227670

Unraveling the autoimmune translational research process layer by layer.

Richard S Blumberg¹, Bonnie Dittel, David Hafler, Matthias von Herrath, Frank O Nestle.

Abstract

Entities: Chemical

Mesh：

Year: 2012 PMID： 22227670 PMCID： PMC4592149 DOI： 10.1038/nm.2632

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

67 in total

1. Clinical application of pharmacogenetics.

Authors: B B Spear; M Heath-Chiozzi; J Huff
Journal: Trends Mol Med Date: 2001-05 Impact factor: 11.951

2. Medicine. The NIH Roadmap.

Authors: Elias Zerhouni
Journal: Science Date: 2003-10-03 Impact factor: 47.728

Review 3. What's next in translational medicine?

Authors: Bruce H Littman; Linda Di Mario; Mario Plebani; Francesco M Marincola
Journal: Clin Sci (Lond) Date: 2007-02 Impact factor: 6.124

4. Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production.

Authors: Peter J Mannon; Ronald L Hornung; Zhiqiong Yang; Chuli Yi; Catherine Groden; Julia Friend; Michael Yao; Warren Strober; Ivan J Fuss
Journal: Gut Date: 2010-10-22 Impact factor: 23.059

Review 5. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases.

Authors: Daniel A Peterson; Daniel N Frank; Norman R Pace; Jeffrey I Gordon
Journal: Cell Host Microbe Date: 2008-06-12 Impact factor: 21.023

6. Reflections on the Innovative Medicines Initiative.

Authors: Michel Goldman
Journal: Nat Rev Drug Discov Date: 2011-05 Impact factor: 84.694

7. Reengineering translational science: the time is right.

Authors: Francis S Collins
Journal: Sci Transl Med Date: 2011-07-06 Impact factor: 17.956

8. Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab.

Authors: Jacqueline M Benson; Clifford W Sachs; George Treacy; Honghui Zhou; Charles E Pendley; Carrie M Brodmerkel; Gopi Shankar; Mary A Mascelli
Journal: Nat Biotechnol Date: 2011-07 Impact factor: 54.908

Review 9. Network medicine: a network-based approach to human disease.

Authors: Albert-László Barabási; Natali Gulbahce; Joseph Loscalzo
Journal: Nat Rev Genet Date: 2011-01 Impact factor: 53.242

10. Materializing research promises: opportunities, priorities and conflicts in translational medicine.

Authors: John PA Ioannidis
Journal: J Transl Med Date: 2004-01-31 Impact factor: 5.531

16 in total

1. Application of user-guided automated cytometric data analysis to large-scale immunoprofiling of invariant natural killer T cells.

Authors: Xinli Hu; Hyun Kim; Patrick J Brennan; Buhm Han; Clare M Baecher-Allan; Philip L De Jager; Michael B Brenner; Soumya Raychaudhuri
Journal: Proc Natl Acad Sci U S A Date: 2013-11-04 Impact factor: 11.205

2. Building the Evidence Base to Inform Planned Intervention Adaptations by Practitioners Serving Health Disparity Populations.

Authors: Jennifer Alvidrez; Anna María Nápoles; Guillermo Bernal; Jacqueline Lloyd; Victoria Cargill; Dionne Godette; Lisa Cooper; Maria Yellow Horse Brave Heart; Rina Das; Tilda Farhat
Journal: Am J Public Health Date: 2019-01 Impact factor: 9.308

Unraveling the autoimmune translational research process layer by layer.

1. Clinical application of pharmacogenetics.

2. Medicine. The NIH Roadmap.

Review 3. What's next in translational medicine?

4. Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production.

Review 5. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases.

6. Reflections on the Innovative Medicines Initiative.

7. Reengineering translational science: the time is right.

8. Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab.

Review 9. Network medicine: a network-based approach to human disease.

10. Materializing research promises: opportunities, priorities and conflicts in translational medicine.

1. Application of user-guided automated cytometric data analysis to large-scale immunoprofiling of invariant natural killer T cells.

2. Building the Evidence Base to Inform Planned Intervention Adaptations by Practitioners Serving Health Disparity Populations.

3. Sideways Progress in Intervention Research Is Not Sufficient to Eliminate Health Disparities.

4. A sweet spot to control complement-induced inflammation.

5. Process evaluation and proximal impact of an affect-based exercise intervention among adolescents.

6. Contribution of poly(ADP-ribose)polymerase-1 activation and apoptosis in trichloroethene-mediated autoimmunity.

7. Calcitriol Regulates the Differentiation of IL-9-Secreting Th9 Cells by Modulating the Transcription Factor PU.1.

8. Achievements in health equity: nesting an NIMHD center of excellence within a CTSA.

9. Control of dichotomic innate and adaptive immune responses by artery tertiary lymphoid organs in atherosclerosis.

Review 10. Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease.